A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer
Clinical trial NCT02210559 · COMPLETED
Trial details
- NCT number
- NCT02210559
- Sponsor
- Kyntra Bio
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-31
- Primary completion
- 2021-12-15
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.